Pharming Group Nv Adr Stock (PHAR) Forecast
The Pharming Group Nv Adr (PHAR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $11.73, representing a -5.87% decrease from the current price of $12.46. The highest analyst price target is $12.22, and the lowest is $11.23.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PHAR Price Target
Average 10.36 (-16.88% Downside)
Is Pharming Group Nv Adr (PHAR) A Buy Now?
Oscillators
Buy: 2 · Sell: 3 · Neutral: 2Summary: Sell
Moving Averages
Buy: 8 · Sell: 2 · Neutral: 0Summary: Buy
According to our latest analysis, PHAR could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on PHAR, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.69 indicates that PHAR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 93.32 indicates that PHAR is overbought. This means that PHAR price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 81.12 indicates that PHAR is overbought. This suggests that PHAR price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 31.16 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of 72.34 indicates that PHAR is still overbought but not to an extreme extent.
Long-term PHAR price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharming Group Nv Adr financial reports and earnings history, Pharming Group Nv Adr (PHAR) stock could reach $17.25 by 2030, $29.20 by 2040 and $37.94 by 2050. See the projected annual prices until 2050 of the Pharming Group Nv Adr stock below:
- Pharming Group Nv Adr (PHAR) is expected to reach an average price of $19.10 in 2035, with a high prediction of $21.75 and a low estimate of $15.45. This indicates an +53.33% change from the last recorded price of $12.46.
- Pharming Group Nv Adr (PHAR) stock is projected to chart a bullish course in 2040, with an average price target of $21.70, representing an +74.12% change from its current level. The forecast ranges from a conservative $20.76 to a sky-high $29.20.
- Our analysts predict Pharming Group Nv Adr (PHAR) to change +128.50% by 2045, soaring from $25.74 to an average price of $28.47, potentially reaching $33.92. While $25.74 is the low estimate, the potential upside is significant.
- Pharming Group Nv Adr (PHAR) stock is expected to climb by 2050, reaching an average of $31.37, a +151.79% change from its current level. However, a wide range of estimates exists, with high and low targets of $37.94 and $19.38, respectively, highlighting the market's uncertainty.
Pharming Group Nv Adr Stock (PHAR) Year by Year Forecast
Pharming Group Nv Adr Stock (PHAR) Price Forecast for 2026
The predicted value for Pharming Group Nv Adr (PHAR) in 2026 is set at an average of $13.70. Estimates vary from a peak of $21.34 to a trough of $9.11, indicating an +9.98% surge from the present price of $12.46.
Pharming Group Nv Adr Stock (PHAR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharming Group Nv Adr (PHAR) is $13.12, with a high forecast of $16.84 and a low forecast of $3.88. This indicates an +5.33% increase from the last price of $12.46.
Pharming Group Nv Adr Stock (PHAR) Price Forecast for 2028
In 2028, Pharming Group Nv Adr (PHAR) is projected to reach an average price of $15.88, with a high projection of $21.84 and a low estimate of $13.67. This indicates an +27.43% rise from the last price of $12.46.
Pharming Group Nv Adr Stock (PHAR) Price Forecast for 2029
The 2029 price forecast for Pharming Group Nv Adr Stock (PHAR) is $14.67 on average, with a high prediction of $17.47 and a low estimate of $11.05. This represents an +17.70% increase from the previous price of $12.46.
Pharming Group Nv Adr Stock (PHAR) Price Forecast for 2030
Pharming Group Nv Adr Stock (PHAR) is expected to reach an average price of $13.70 in 2030, with a high forecast of $17.25 and a low forecast of $11.16. This signifies an +9.96% surge from the last price of $12.46.
